of SARS‐CoV
S protein‐ACE2 blockers  Human mAb  SARS‐CoV   Neutralizing SARS‐CoV, inhibiting syncytia formation between cells expressing the S protein and the SARS‐CoV receptor ACE2
Chloroquine  SARS‐CoV   Possess antiviral effect, inhibiting of SARS‐CoV infection via interfering with ACE2
Emodin  SARS‐CoV   Blocking the interaction between the S protein of virus and ACE2
Promazine  SARS‐CoV   Inhibiting the replication of virus, inhibiting the binding of S protein to